Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | SRRA | INDV | AVDL | ||
Company | Sierra Oncology Inc | Indivior Plc | Avadel Pharmaceuticals Plc ADR | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 54.98 | 9.80 | 13.86 | ||
High | 55.17 | 9.84 | 14.00 | ||
Low | 54.98 | 9.65 | 13.49 | ||
Last | 54.99 | 9.68 | 13.60 | ||
Change | +0.02 | -0.09 | -0.05 | ||
% Change | +0.04% | -0.92% | -0.37% | ||
Volume | 862,800 | 798,500 | 1,085,100 | ||
20-Day Average Volume | 396,690 | 1,070,500 | 1,046,215 | ||
Previous Close | 54.97 | 9.77 | 13.65 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 54.91 | 10.99 | 14.67 | ||
20-Day Raw Stochastic | 62.96% | 10.26% | 4.47% | ||
20-Day Relative Strength | 77.35% | 32.73% | 35.82% | ||
Weighted Alpha | +89.10 | -57.09 | +7.63 | ||
Today's Opinion | 100% Buy | 100% Sell | 72% Sell | ||
Previous Opinion | 100% Buy | 100% Sell | 72% Sell | ||
Last Month's Opinion | 100% Buy | 100% Sell | 16% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +0.07% since 06/23/22 | +0.62% since 09/12/24 | -2.47% since 09/12/24 | ||
Low | 54.65 on 06/24/22 | 9.47 on 09/17/24 | 13.49 on 09/19/24 | ||
High | 55.19 on 06/24/22 | 9.97 on 09/18/24 | 14.14 on 09/16/24 | ||
1-Month | |||||
%Chg | +0.38% since 05/27/22 | -23.24% since 08/19/24 | -15.79% since 08/19/24 | ||
Low | 54.58 on 05/31/22 | 9.33 on 09/11/24 | 13.46 on 09/11/24 | ||
High | 55.19 on 06/24/22 | 12.74 on 08/27/24 | 16.59 on 08/23/24 | ||
3-Month | |||||
%Chg | +69.83% since 03/30/22 | -38.97% since 06/18/24 | -12.82% since 06/18/24 | ||
Low | 30.87 on 03/31/22 | 9.14 on 07/09/24 | 13.42 on 06/28/24 | ||
High | 55.19 on 06/24/22 | 16.98 on 06/21/24 | 17.30 on 08/08/24 | ||
6-Month | |||||
%Chg | +144.40% since 12/30/21 | -53.93% since 03/19/24 | -13.92% since 03/19/24 | ||
Low | 14.91 on 01/24/22 | 9.14 on 07/09/24 | 13.42 on 06/28/24 | ||
High | 55.19 on 06/24/22 | 22.53 on 04/04/24 | 19.09 on 05/03/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 1,342,801 | 1,347,078 | 1,312,024 | ||
Shares Outstanding, K | 24,419 | 137,879 | 96,119 | ||
Annual Sales | 0 | 1,093,000,000 | 27,960,000 | ||
Annual Net Income | -94,660,000 | 2,000,000 | -160,280,000 | ||
Last Quarter Sales | 0 | 299,000,000 | 41,500,000 | ||
Last Quarter Net Income | -27,930,000 | -107,000,000 | -13,820,000 | ||
60-Month Beta | 0.01 | 0.68 | 1.53 | ||
Per-Share Information | |||||
Most Recent Earnings | -1.33 on 05/06/22 | 0.44 on 07/25/24 | -0.14 on 08/08/24 | ||
Latest Earnings Date | 08/04/22 | 07/25/24 | 08/08/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 6.02 | 0.00 |